230 related articles for article (PubMed ID: 26467186)
21. Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression.
Sartoretto JL; Melo GA; Carvalho MH; Nigro D; Passaglia RT; Scavone C; Cuman RK; Fortes ZB
Life Sci; 2005 Oct; 77(21):2676-89. PubMed ID: 15964597
[TBL] [Abstract][Full Text] [Related]
22. Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model.
Takahashi N; Shibata R; Ouchi N; Sugimoto M; Murohara T; Komori K
J Vasc Surg; 2015 Feb; 61(2):489-96. PubMed ID: 24993950
[TBL] [Abstract][Full Text] [Related]
23. Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.
Bhardwaj P; Khanna D; Balakumar P
Cardiovasc Toxicol; 2014 Mar; 14(1):41-51. PubMed ID: 24048981
[TBL] [Abstract][Full Text] [Related]
24. Estradiol-mediated endothelial nitric oxide synthase association with heat shock protein 90 requires adenosine monophosphate-dependent protein kinase.
Schulz E; Anter E; Zou MH; Keaney JF
Circulation; 2005 Jun; 111(25):3473-80. PubMed ID: 15967841
[TBL] [Abstract][Full Text] [Related]
25. Nifedipine prevents vascular endothelial dysfunction in a mouse model of obesity and type 2 diabetes, by improving eNOS dysfunction and dephosphorylation.
Yamamoto E; Nakamura T; Kataoka K; Tokutomi Y; Dong YF; Fukuda M; Nako H; Yasuda O; Ogawa H; Kim-Mitsuyama S
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):258-63. PubMed ID: 21059340
[TBL] [Abstract][Full Text] [Related]
26. Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain.
Wang S; Peng Q; Zhang J; Liu L
Cardiovasc Res; 2008 Nov; 80(2):255-62. PubMed ID: 18591204
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol rescues hyperglycemia-induced endothelial dysfunction via activation of Akt.
Li JY; Huang WQ; Tu RH; Zhong GQ; Luo BB; He Y
Acta Pharmacol Sin; 2017 Feb; 38(2):182-191. PubMed ID: 27941804
[TBL] [Abstract][Full Text] [Related]
28. Essential role of bone marrow for microvascular endothelial and metabolic functions in mice.
Nakajima S; Ohashi J; Sawada A; Noda K; Fukumoto Y; Shimokawa H
Circ Res; 2012 Jun; 111(1):87-96. PubMed ID: 22550140
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylated PKM2 regulates endothelium-dependent vasodilation in diabetes.
Lu B; Tang L; Li L; Zhou X; Leng Y; Quan C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):663-670. PubMed ID: 37539568
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of bone morphogenic protein 4 restores endothelial function in db/db diabetic mice.
Zhang Y; Liu J; Tian XY; Wong WT; Chen Y; Wang L; Luo J; Cheang WS; Lau CW; Kwan KM; Wang N; Yao X; Huang Y
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):152-9. PubMed ID: 24202302
[TBL] [Abstract][Full Text] [Related]
31. Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null mice.
Pojoga LH; Yao TM; Opsasnick LA; Garza AE; Reslan OM; Adler GK; Williams GH; Khalil RA
J Pharmacol Exp Ther; 2014 Feb; 348(2):260-70. PubMed ID: 24281385
[TBL] [Abstract][Full Text] [Related]
32. Molecular Interplay between microRNA-34a and Sirtuin1 in Hyperglycemia-Mediated Impaired Angiogenesis in Endothelial Cells: Effects of Metformin.
Arunachalam G; Lakshmanan AP; Samuel SM; Triggle CR; Ding H
J Pharmacol Exp Ther; 2016 Feb; 356(2):314-23. PubMed ID: 26582729
[TBL] [Abstract][Full Text] [Related]
33. [Aortic endothelium-dependent vasodilation function and PI3K-, PKB-, eNOS mRNA expressions in insulin-resistant and type 2 diabetic rats].
Wu J; Lei MX; Liu L; Xie XY
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Mar; 35(3):265-70. PubMed ID: 17582297
[TBL] [Abstract][Full Text] [Related]
34. Bone Morphogenic Protein 4 Mediates NOX1-Dependent eNOS Uncoupling, Endothelial Dysfunction, and COX2 Induction in Type 2 Diabetes Mellitus.
Youn JY; Zhou J; Cai H
Mol Endocrinol; 2015 Aug; 29(8):1123-33. PubMed ID: 26121233
[TBL] [Abstract][Full Text] [Related]
35. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site.
Du XL; Edelstein D; Dimmeler S; Ju Q; Sui C; Brownlee M
J Clin Invest; 2001 Nov; 108(9):1341-8. PubMed ID: 11696579
[TBL] [Abstract][Full Text] [Related]
36. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
[TBL] [Abstract][Full Text] [Related]
37. Suppressed G-protein-coupled receptor kinase 2 activity protects female diabetic-mouse aorta against endothelial dysfunction.
Taguchi K; Matsumoto T; Kamata K; Kobayashi T
Acta Physiol (Oxf); 2013 Jan; 207(1):142-55. PubMed ID: 22925038
[TBL] [Abstract][Full Text] [Related]
38. A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice.
Howarth AG; Wiehler WB; Pannirselvam M; Jiang Y; Berger JP; Severson D; Anderson TJ; Triggle CR
J Pharmacol Exp Ther; 2006 Jan; 316(1):364-70. PubMed ID: 16249369
[TBL] [Abstract][Full Text] [Related]
39. TRAIL protects against endothelium injury in diabetes via Akt-eNOS signaling.
Liu M; Xiang G; Lu J; Xiang L; Dong J; Mei W
Atherosclerosis; 2014 Dec; 237(2):718-24. PubMed ID: 25463111
[TBL] [Abstract][Full Text] [Related]
40. The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes.
Huang SS; Lu YJ; Huang JP; Wu YT; Day YJ; Hung LM
J Vasc Surg; 2014 Feb; 59(2):483-91. PubMed ID: 23663869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
